Bridgeside Point II
In December of 2009, the department's Chairman, administrative personnel and the majority of the department's faculty and research labs were relocated from the Thomas E. Starzl Biomedical Science Tower in Oakland to a newly constructed facility, called Bridgeside Point II. MMG occupies the 4th and 5th floors of the building. The space houses the Chairman's office, administrative suite, faculty offices, research laboratories, common departmental research equipment areas, seminar rooms, conference rooms and common gathering areas.
Biomedical Science Tower 3
Biomedical Science Tower 3 opened in 2005. Within the 10-story, 330,000-square-foot facility, world-class scientists from an array of disciplines pool their expertise, extend the reach of their individual resources, and participate in discoveries that advance scientific understanding. The tower was engineered to facilitate coordinated research in the areas of neurosciences, vaccine development, drug discovery, regenerative medicine and biomedical devices, and basic science disciplines.
Hillman Cancer Center
For more than 30 years, UPMC Hillman Cancer Center has been committed to all aspects of cancer care. The internationally renowned research at UPMC Hillman Cancer Center (formerly the University of Pittsburgh Cancer Institute) includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care; our researchers collaborate with our clinician-scientists to advance the most promising laboratory studies into novel clinical trials, providing patients with early access to new and innovated treatments.